Cys-141 glutathionylation of human p53: Studies using specific polyclonal antibodies in cancer samples and cell lines.
about
Targeting Oncogenic Mutant p53 for Cancer TherapyRedox homeostasis: the linchpin in stem cell self-renewal and differentiationInhibition of glutathione synthesis distinctly alters mitochondrial and cytosolic redox poiseOxidative stress induced S-glutathionylation and proteolytic degradation of mitochondrial thymidine kinase 2New insights into the link between DNA damage and apoptosis.Cellular redox imbalance and changes of protein S-glutathionylation patterns are associated with senescence induced by oncogenic H-rasReversible and irreversible protein glutathionylation: biological and clinical aspects.Recent advances in proteomics: towards the human proteome.Regulatory control or oxidative damage? Proteomic approaches to interrogate the role of cysteine oxidation status in biological processes.Degradation of NF-κB, p53 and other regulatory redox-sensitive proteins by thiol-conjugating and -nitrosylating drugs in human tumor cells.S-glutathiolation in life and death decisions of the cell.Proteomics, genomics and transcriptomics: their emerging roles in the discovery and validation of colorectal cancer biomarkers.The antioxidant paradox: what are antioxidants and how should they be used in a therapeutic context for cancer.Effect of S-nitrosoglutathione on renal mitochondrial function: a new mechanism for reversible regulation of manganese superoxide dismutase activity?Quantitative proteomic characterization of redox-dependent post-translational modifications on protein cysteines.Regulation of signal transduction by glutathione transferases.Upregulated glutathione transferase omega-1 correlates with progression of urinary bladder carcinoma.Protein Glutathionylation in the Pathogenesis of Neurodegenerative Diseases.
P2860
Q26770856-5C2802DE-6817-4A24-B069-E44BDA173450Q28396335-06B58272-CA9D-4FA6-A636-A42234CBEC84Q33997792-1B9E4D43-9196-4ACC-B34A-2E9E9E909CD5Q34278809-33F28261-B95F-4C89-81F1-D490E945B47AQ34425503-644EAAA8-9ED5-48D3-A465-B1EA25639FD3Q34533152-14A2EF45-F67D-496B-B472-BAA324EA5C19Q35048314-5769C703-9FC0-4E71-963A-ED241616CE94Q35174151-07EA7306-CB98-432F-B7DC-CD119505F7EBQ35878798-892078BB-AAB8-4321-A25E-CBD650789690Q36814016-73083327-90DD-48A9-9FF4-D87704A09801Q37785101-2FA88F76-8921-4BA0-A08F-BD248290ED28Q38194582-A63EA574-CFD5-490E-B97B-3DF4A7930B0DQ38261369-3A933D9F-4C39-4D4A-AE42-8703AAC38D12Q38680661-7D2C82DA-BFDC-4E42-8218-15DFF9BA21E5Q39208212-90E3AA98-6753-40E5-953F-81BDFEA0A85EQ41901021-0B848591-F4DC-4B03-A701-74969955B40CQ48134226-7AE31637-0538-4474-AD3F-8B287DF21D41Q49874478-7546F59A-DA63-400F-97B7-DAC9095B761E
P2860
Cys-141 glutathionylation of human p53: Studies using specific polyclonal antibodies in cancer samples and cell lines.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cys-141 glutathionylation of h ...... cancer samples and cell lines.
@ast
Cys-141 glutathionylation of h ...... cancer samples and cell lines.
@en
Cys-141 glutathionylation of h ...... cancer samples and cell lines.
@nl
type
label
Cys-141 glutathionylation of h ...... cancer samples and cell lines.
@ast
Cys-141 glutathionylation of h ...... cancer samples and cell lines.
@en
Cys-141 glutathionylation of h ...... cancer samples and cell lines.
@nl
prefLabel
Cys-141 glutathionylation of h ...... cancer samples and cell lines.
@ast
Cys-141 glutathionylation of h ...... cancer samples and cell lines.
@en
Cys-141 glutathionylation of h ...... cancer samples and cell lines.
@nl
P2093
P2860
P1476
Cys-141 glutathionylation of h ...... cancer samples and cell lines.
@en
P2093
G Jayarama Bhat
Kalkunte S Srivenugopal
Mohd A Yusuf
Trinette Chuang
P2860
P304
P356
10.1016/J.FREERADBIOMED.2010.06.020
P577
2010-06-25T00:00:00Z